He Eye Specialist Hospital Group was founded by Dr He Wei, a professor, chief physician, doctor of medicine, and doctoral supervisor, who returned to his home country after finishing his overseas study. Vice President of the National Prevention of Blindness Technical Guidance Committee, Board member of the Ophthalmology Foundation. His team is a group chain medical institution that integrates medical teaching and research, adopts a tertiary eye care service model, and is committed to eye health management through the whole life cycle.
On March 22, 2022, He Eye Specialist Hospital Group made its initial public offering on the Shenzhen Stock Exchange and was listed on the GEM (301103. SZ).
With the mission of “He Eye care services to everyone”, He’s Eye Care adheres to the development concept of “Technology & Compassion”, insists on prevention-oriented and combined prevention and treatment, and provides ophthalmology and optometry services for eye disease patients. We have rich clinical experience and outstanding technical advantages in cataract, glaucoma, vitreoretinopathy, dry eye, Chinese medicine, refractive error and other treatment services.
Dr He Wei and his team have introduced phacoemulsification, vitrectomy and fundus laser technology since the early days of their business in 1995. At the same time, they were using innovative technology to establish and improve He Eye’s characteristic tertiary eye health medical service model. Currently, the model is based on Internet technology and integrates online and offline resources, enabling offline services to continuously extend to pre-consultation, consultation and post-consultation, building a medical service system centred on personal eye health and effectively supporting the continuous and rapid development of the business.
Given the comprehensive ability of the medical technology team, medical service capacity and level, medical quality, scientific research and teaching, Shenyang He Eye Specialist Hospital, the central hospital of the Group, was awarded as “National Key Clinical Specialties” and is also the “Training Base for Prevention and Treatment of Blindness” of the National Health Care Commission. “Ltd., the training base for ophthalmologists of the International Council of Ophthalmology and the national drug clinical trial institution, Shenyang He Eye Specialist Hospital. is an ISO9001 international quality management system certificated unit.
Proactive social responsibility is the embodiment of He Eye Specialist Hospital’s value of “Work with a common purpose “. With a high sense of responsibility and mission, He Eye Specialist Hospital practices social responsibility by promoting advocacy, education, training, and public welfare and others, becoming an important force in promoting the development of eye health. He Eye Specialist Hospital has been awarded the “People’s Corporate Social Responsibility Award” by People’s Daily Online and “the 2020 Demonstration Project for People’s Livelihood” by the national government. The company has also been listed on the United Nations Global Compact China Network’s “Corporate Best Practice” list.
In the future, He Eye Specialist Hospital will keep up with the time, persist in technological innovation, accelerate talent training, promote regional layout, strengthen international cooperation, fulfil social responsibility, and continue to provide high-quality eye care services for the people.
The eye, which is more easily accessible than organs shielded by skin and muscle, often reveals insights into a patient’s overall state of health. The Wilmer Eye Institute’s Annual Report details stories of lifesaving discoveries, innovative educational initiatives, and groundbreaking research that are advancing patient care and the field of ophthalmology. Read the report: https://www.hopkinsmedicine.org/news/publications/wilmer_issues/annual-report-2022
REMINDER: Call for Projects Interested in funding for a project? The WAEH can finance two to three projects per year with 7.500,- euro. You can use the following WAEH project format to send in your project proposal: WAEH project proposal.Round 1 – Deadline 31 January 2023– Incoming proposals reviewed by board in February / March board meeting– […]
Longitudinal Use of Telehealth During the COVID-19 Pandemic and Utility of Asynchronous Testing for Subspecialty-Level Ophthalmic Care
Publication by WAEH Member UCSF – Department of Ophthalmology Importance: Telehealth in ophthalmology has traditionally focused on preventive disease screening with limited use in outpatient evaluation. The unique conditions of the COVID-19 pandemic afforded the opportunity to evaluate different implementations of teleophthalmology at scale, providing insight into expanding teleophthalmology care. Objective: To compare telehealth use in ophthalmology […]
The Victoria Cohen Scholarship 2023/24 – open for applications
The Victoria Cohen Scholarship is now open for applications from aspiring ocular oncologists in need of financial support throughout their fellowship. The Victoria Cohen Eye Cancer Charitable Trust was established in 2021 in memory of the late Victoria Cohen, former president of ISOO. Victoria was always keen to support the next generation of eye surgeons […]
Eye cancer is a terrible disease and there are not enough ocular oncologists in the world. Training takes time and money. The Victoria Cohen Eye Cancer Charitable Trust provides scholarships to support aspiring ocular oncologists through their training and education. The deadline for applications for the Victoria Cohen Scholarship 2023/24 is the 31st March 2023. For […]